Jane Street Group, LLC Xeris Biopharma Holdings, Inc. Transaction History
Jane Street Group, LLC
- $444 Billion
- Q4 2024
A detailed history of Jane Street Group, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 306,245 shares of XERS stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
306,245
Previous 318,760
3.93%
Holding current value
$1.1 Million
Previous $908,000
14.32%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding XERS
# of Institutions
162Shares Held
61.5MCall Options Held
34.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY10.3MShares$37.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$28.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.35MShares$12 Million0.0% of portfolio
-
State Street Corp Boston, MA3.34MShares$12 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.88MShares$10.3 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $488M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...